Explore this test

  • Test Details
  • Lab Values
  • Clinical Significance
  • Treatment Options
DOWNLOAD SPECIMEN PREP FLYER

Explore this test

Test Code 436 (IGF-1 alone) or 437 (IGF-1 with Z-score)

Test Details

Insulin Like Growth Factor 1 (IGF-1)

IGF-1 is a hormone that manages the effects of growth hormone (GH) in the body. Together, IGF-1 and GH promote normal growth of bones and tissues. GH levels in the blood fluctuate throughout the day depending on diet and activity levels, but IGF-1 levels remain stable. The IGF-1 test is a useful way to find out if the body is making a normal amount of GH.

Methodology

Immunoassay

Patient Preparation

None

Preferred Specimen

1.0 mL serum (0.5 mL minimum) collected in serum separator tube (SST / Tiger Top)

Alternate Specimen

1.0 mL plasma (0.5 mL minimum) collected in white/pearl top tube

Transport Temperature

Refrigerated (ship on frozen cold packs)

Stability

  • 1 day at room temperature.
  • 2 days at 2-8°C.
Lab Values

Lab Values

Insulin Like Growth Factor 1 (IGF-1)

  • IGF-1 normal ranges

    The IGF-1 normal ranges are listed as 2.5th and 97.5th percentile values based on age and sex. Median values are also provided.

VIEW FEMALE REFERENCE RANGES
 
VIEW MALE REFERENCE RANGES
 

  • Z-score

    The z-score is the standard deviation score that enables providers to easily determine if a test result is within the range of the expected value. Further, the z-score makes results comparable with other assays.

    • The values, -/+ 1.96, for the z-scores are derived from the percentiles of the standard normal distribution and correspond to the 2.5% percentile and the 97.5% percentile.
    • In this respect, the z-score range between -1.96 and +1.96 corresponds to the central 95% range.
    • A z-score within the range of -1.96 and +1.96 is considered normal and z-score outside this range is below respectively above the expected values.

 

Female Reference Ranges


 

AgeGenderReference Range (ng/mL)Median Value (ng/mL)
<=1F18.7-10455.3
2F26.1-12865.0
3F34.2-15576.0
4F43.2-18588.2
5F53.0-216102
6F63.6-250116
7F75.0-286133
8F87.3-324154
9F99.9-363180
10F112-398210
11F123-427244
12F132-451278
13F140-468306
14F146-480325
15F151-485331
16F154-485324
17F156-479305
18F156-466283
19F155-449261
20F152-429243
21F148-410227
22F143-392214
23F138-375203
24F134-359195
25F130-343189
26F126-329185
27F122-315182
28F118-303179
29F115-292176
30F112-281173
31F109-271171
32F107-263169
33F104-255167
34F102-248165
35F100-242163
36F98.3-238160
37F96.5-234158
38F94.8-231155
39F93.1-228153
40F91.4-227150
41F89.8-225147
42F88.1-224145
43F86.5-222142
44F84.9-221139
45F83.3-220136
46F81.8-219132
47F80.2-218130
48F78.7-218127
49F77.2-217125
50F75.7-215123
51F74.3-214121
52F72.8-212120
53F71.4-210119
54F70.0-207118
55F68.6-204117
56F67.3-201117
57F65.9-198116
58F64.6-194115
59F63.3-190114
60F62.0-186113
61F60.7-182112
62F59.5-179111
63F58.3-176110
64F57.3-173109
65F56.3-170108
66F55.5-168106
67F54.8-166105
68F54.2-164104
69F53.8-163102
70F53.5-162101
71F53.3-16199.8
72F53.2-16098.7
73F53.2-16097.6
74F53.3-16096.7
75F53.5-16095.8
76F53.7-16195.1
77F54.0-16294.4
78F54.3-16393.9
79F54.7-16493.4
80F55.1-16693.0

 

Male Reference Ranges


 

AgeGenderReference Range (ng/mL)Median Value (ng/mL)
<=1M11.8-96.444.4
2M13.9-10451.7
3M18.9-11660.5
4M26.8-13470.6
5M36.6-15681.9
6M47.1-18494.5
7M57.5-216108
8M67.5-254123
9M76.9-296141
10M85.7-343164
11M93.9-392194
12M101-434231
13M108-467270
14M115-489304
15M120-501327
16M125-503339
17M129-495340
18M132-476331
19M134-450312
20M136-421291
21M137-394272
22M137-370254
23M136-348238
24M135-328225
25M132-310213
26M130-295203
27M128-282194
28M125-271188
29M123-263183
30M120-257180
31M118-253176
32M116-250173
33M114-247170
34M111-244166
35M109-242163
36M107-239160
37M105-236158
38M103-234155
39M101-231152
40M98.5-229150
41M96.4-226148
42M94.4-223146
43M92.4-221144
44M90.5-218142
45M88.5-216140
46M86.5-214139
47M84.6-211137
48M82.6-209136
49M80.6-207135
50M78.7-205133
51M76.7-203132
52M74.8-201130
53M72.8-200129
54M70.9-198127
55M68.9-196126
56M67.0-195124
57M65.3-194122
58M63.7-193121
59M62.3-192119
60M61.1-191118
61M60.0-190117
62M59.2-189116
63M58.5-188116
64M57.9-188115
65M57.4-187115
66M56.8-186115
67M56.3-186115
68M55.8-185115
69M55.2-185114
70M54.7-185114
71M54.1-184113
72M53.6-184111
73M53.0-184110
74M52.4-184108
75M51.9-184106
76M51.3-184104
77M50.7-184102
78M50.2-18499
79M49.6-18496.1
Test Details
Clinical Significance

Clinical Significance

Insulin Like Growth Factor 1 (IGF-1)

  • Very Low Values

    Very low values are associated with growth hormone deficiency and short stature in children and adolescents (<17 years of age). Very low IGF-1 has also been associated with fatty liver disease, liver fibrosis, increased risk of diabetes and heart failure in adults.

  • Very High Values

    Very high values are associated with growth hormone excess and acromegaly, as well as delayed puberty, pregnancy, hyperthyroidism, and high protein diets.

Lab Values
Treatment Options

Treatment Options

Insulin Like Growth Factor 1 (IGF-1)

Treatment for Low IGF-1 Levels:

Low IGF-1 levels are often related to growth hormone (GH) deficiency, which can occur due to pituitary gland issues or other underlying conditions.
Growth Hormone Therapy:

  • Human Growth Hormone (HGH) Replacement: Administering synthetic HGH can help increase IGF-1 levels. It’s typically given as a daily injection and is used in children with growth failure or adults with GH deficiency.

Managing Underlying Conditions:

  • If a medical condition like hypothyroidism or malnutrition is causing low IGF-1, treating the underlying issue may help restore IGF-1 levels.

Diet and Lifestyle Adjustments:

  • Adequate nutrition and managing stress levels can positively affect IGF-1 levels. Consuming sufficient protein and essential nutrients is key to supporting normal growth factor production.

IGF-1 Replacement Therapy:

  • In rare cases, direct IGF-1 therapy (Mecasermin) may be prescribed for children with severe IGF-1 deficiency who do not respond well to GH therapy.

 

Treatment for High IGF-1 Levels:

Elevated IGF-1 is often associated with conditions like acromegaly (usually due to excess GH secretion, often caused by a pituitary tumor).
Surgical Treatment (Pituitary Tumor):

  • If a pituitary tumor is causing excessive GH and IGF-1 production, surgery to remove the tumor (transsphenoidal surgery) is the first-line treatment.

Medication:/strong>

  • Somatostatin Analogues (e.g., Octreotide, Lanreotide): These drugs inhibit GH secretion and help reduce IGF-1 levels.
  • GH Receptor Antagonists (e.g., Pegvisomant): These block GH receptors and reduce IGF-1 production.
  • Dopamine Agonists (e.g., Cabergoline): Sometimes used to control GH secretion, particularly in combination with other therapies.

Radiation Therapy:

  • If surgery and medications are insufficient, radiation therapy may be used to target the pituitary gland and reduce tumor size, ultimately lowering IGF-1 levels.

Regular Monitoring:

  • For both low and high IGF-1, regular monitoring of IGF-1 and GH levels, along with other hormonal assessments, is important to track treatment progress and adjust therapy as needed.

It’s essential to work with an endocrinologist for proper diagnosis and to design a treatment plan specific to the underlying cause.

Clinical Significance